BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37743335)

  • 1. [Mesenchymal and Non-meningothelial Tumors Involving the Central Nervous System].
    Oya S; Murakami C
    No Shinkei Geka; 2023 Sep; 51(5):837-844. PubMed ID: 37743335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities.
    Tauziède-Espariat A; Hasty L; Métais A; Varlet P
    Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the spectrum of "mesenchymal" tumors of the central nervous system.
    Pizzimenti C; Gianno F; Gessi M
    Pathologica; 2022 Dec; 114(6):455-464. PubMed ID: 36534424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement.
    d'Amati A; Gianno F; Scuccimarri L; Lastilla M; Messina R; Signorelli F; Zimatore DS; Barresi S; Miele E; Alaggio R; Rossi S; Maiorano E; Ingravallo G; Giangaspero F; Antonelli M
    Acta Neuropathol Commun; 2023 Jun; 11(1):95. PubMed ID: 37312212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system tumors of uncertain differentiation.
    A Jacobo J
    World Neurosurg X; 2024 Apr; 22():100349. PubMed ID: 38455248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some CNS sarcomas seen: A 22-year series.
    Kleinschmidt-DeMasters BK; Gilani A
    Clin Neuropathol; 2023; 42(2):54-65. PubMed ID: 36708209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sarcomas of the central nervous systems. Clinical observations].
    Ryzhova MV; Galstyan SA; Telysheva EN; Shaikhaev EG; Snigireva GP; Gorelyshev SK; Kadyrov SU; Shimanskiy VN; Shugay SV; Panina TN
    Arkh Patol; 2022; 84(3):40-47. PubMed ID: 35639842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.
    Sloan EA; Gupta R; Koelsche C; Chiang J; Villanueva-Meyer JE; Alexandrescu S; Eschbacher JM; Wang W; Mafra M; Ud Din N; Carr-Boyd E; Watson M; Punsoni M; Oviedo A; Gilani A; Kleinschmidt-DeMasters BK; Coss DJ; Lopes MB; Reddy A; Mueller S; Cho SJ; Horvai AE; Lee JC; Pekmezci M; Tihan T; Bollen AW; Rodriguez FJ; Ellison DW; Perry A; von Deimling A; Chang SM; Berger MS; Solomon DA
    Brain Pathol; 2022 Jul; 32(4):e13037. PubMed ID: 34821426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes.
    Tauziède-Espariat A; Pierron G; Guillemot D; Sievers P; Cazals-Hatem D; Faillot T; Roux A; Benzakoun J; Bockel S; Weinbreck N; Hasty L; Lechapt E; Chrétien F; Varlet P
    Acta Neuropathol Commun; 2021 Oct; 9(1):174. PubMed ID: 34715942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant.
    Wolf T; Coca AH; Weingertner N; Chenard MP; Meurgey A; Reita D; Pencreach E; Varlet P; Entz-Werlé N; Lhermitte B
    Virchows Arch; 2023 Feb; 482(2):431-435. PubMed ID: 36307659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.
    Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL
    Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant.
    Alexandrescu S; Meredith DM; Lidov HG; Alaggio R; Novello M; Ligon KL; Vargas SO
    Histopathology; 2021 Jan; 78(2):265-275. PubMed ID: 32692439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DICER1-associated central nervous system sarcoma with neural lineage differentiation: a case report.
    Yao K; Duan Z; Feng J; Yan C; Qi X
    Diagn Pathol; 2022 Sep; 17(1):72. PubMed ID: 36153506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.
    Tauziède-Espariat A; Sievers P; Larousserie F; Benzakoun J; Guillemot D; Pierron G; Duchesne M; Uro-Coste E; Roux A; Vasiljevic A; Fenouil T; Meyronet D; Mokhtari K; Polivka M; Rousseau A; Bost-Bezeaud F; Akoury S; Pallud J; Benevello C; Hasty L; Gareton A; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Puget S; Sahm F; Varlet P;
    Brain Pathol; 2022 Jan; 32(1):e13010. PubMed ID: 34314078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of pediatric soft tissue tumors with review of conventional MRI appearance-part 1: tumor-like lesions, adipocytic tumors, fibroblastic and myofibroblastic tumors, and perivascular tumors.
    Porrino J; Al-Dasuqi K; Irshaid L; Wang A; Kani K; Haims A; Maloney E
    Skeletal Radiol; 2022 Mar; 51(3):477-504. PubMed ID: 34191084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC-rearranged sarcoma.
    Satomi K; Ohno M; Kubo T; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Ichikawa H; Yoshida A
    Genes Chromosomes Cancer; 2022 Nov; 61(11):683-688. PubMed ID: 35715887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
    Gojo J; Kjaersgaard M; Zezschwitz BV; Capper D; Tietze A; Kool M; Haberler C; Pizer B; Hoff KV
    Eur J Med Genet; 2023 Jan; 66(1):104660. PubMed ID: 36356895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal, non-meningothelial tumors of the central nervous system.
    Jellinger K; Paulus W
    Brain Pathol; 1991 Jan; 1(2):79-87. PubMed ID: 1669699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of pediatric soft tissue tumors with review of conventional MRI appearance-part 2: vascular lesions, fibrohistiocytic tumors, muscle tumors, peripheral nerve sheath tumors, tumors of uncertain differentiation, and undifferentiated small round cell sarcomas.
    Maloney E; Al-Dasuqi K; Irshaid L; Wang A; Kani K; Haims A; Porrino J
    Skeletal Radiol; 2022 Apr; 51(4):701-725. PubMed ID: 34297167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.